DE69637524D1 - Das h-y antigen - Google Patents
Das h-y antigenInfo
- Publication number
- DE69637524D1 DE69637524D1 DE69637524T DE69637524T DE69637524D1 DE 69637524 D1 DE69637524 D1 DE 69637524D1 DE 69637524 T DE69637524 T DE 69637524T DE 69637524 T DE69637524 T DE 69637524T DE 69637524 D1 DE69637524 D1 DE 69637524D1
- Authority
- DE
- Germany
- Prior art keywords
- peptide
- seq
- histocompatibility antigen
- minor histocompatibility
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95202067 | 1995-07-27 | ||
| PCT/NL1996/000307 WO1997005168A1 (en) | 1995-07-27 | 1996-07-29 | The h-y antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69637524D1 true DE69637524D1 (de) | 2008-06-26 |
Family
ID=8220537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69637524T Expired - Fee Related DE69637524D1 (de) | 1995-07-27 | 1996-07-29 | Das h-y antigen |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6521598B1 (de) |
| EP (1) | EP0840749B1 (de) |
| JP (1) | JPH11511129A (de) |
| AT (1) | ATE395361T1 (de) |
| AU (1) | AU723937B2 (de) |
| CA (1) | CA2224894A1 (de) |
| DE (1) | DE69637524D1 (de) |
| NZ (1) | NZ313774A (de) |
| WO (1) | WO1997005168A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060159690A1 (en) * | 1995-07-27 | 2006-07-20 | Rijksuniversiteit Te Leiden | H-Y antigen |
| JP2001510851A (ja) | 1997-07-23 | 2001-08-07 | リュークスウニベルジテート トゥ ライデン | Ｈａ−１抗原 |
| US20040092446A1 (en) * | 1997-07-23 | 2004-05-13 | Goulmy Elsa A.J.M. | HA-1 epitopes and uses thereof |
| EP1067141A1 (de) * | 1999-06-11 | 2001-01-10 | Rijksuniversiteit te Leiden | Ein für Männer spezifisches Proteinhomologes, das im Zusammenhang mit der Histokompatibilität steht |
| CA2489296A1 (en) | 2002-06-13 | 2003-12-24 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| BRPI0401765C1 (pt) * | 2004-05-17 | 2011-03-15 | Hy Biotecnologica Ltda | método de enriquecimento de espermatozoides de mamìferos portadores de cromossomo x ou de cromossomo y |
| US7576323B2 (en) | 2004-09-27 | 2009-08-18 | Johns Hopkins University | Point-of-care mass spectrometer system |
| GB0918862D0 (en) * | 2009-10-27 | 2009-12-09 | Glaxo Group Ltd | Method of treatment |
| EP2803363B1 (de) | 2013-05-13 | 2017-04-05 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz | Das Antigen CYBA-72Y/B15 und Verwendungen davon |
-
1996
- 1996-07-29 NZ NZ313774A patent/NZ313774A/xx unknown
- 1996-07-29 WO PCT/NL1996/000307 patent/WO1997005168A1/en active Application Filing
- 1996-07-29 CA CA002224894A patent/CA2224894A1/en not_active Abandoned
- 1996-07-29 EP EP96926013A patent/EP0840749B1/de not_active Expired - Lifetime
- 1996-07-29 JP JP9507499A patent/JPH11511129A/ja not_active Ceased
- 1996-07-29 DE DE69637524T patent/DE69637524D1/de not_active Expired - Fee Related
- 1996-07-29 AU AU66317/96A patent/AU723937B2/en not_active Ceased
- 1996-07-29 US US09/000,217 patent/US6521598B1/en not_active Expired - Fee Related
- 1996-07-29 AT AT96926013T patent/ATE395361T1/de not_active IP Right Cessation
-
2002
- 2002-12-24 US US10/328,927 patent/US7008922B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0840749A1 (de) | 1998-05-13 |
| EP0840749B1 (de) | 2008-05-14 |
| CA2224894A1 (en) | 1997-02-13 |
| ATE395361T1 (de) | 2008-05-15 |
| US7008922B2 (en) | 2006-03-07 |
| US6521598B1 (en) | 2003-02-18 |
| AU723937B2 (en) | 2000-09-07 |
| US20030181370A1 (en) | 2003-09-25 |
| NZ313774A (en) | 1999-11-29 |
| JPH11511129A (ja) | 1999-09-28 |
| WO1997005168A1 (en) | 1997-02-13 |
| AU6631796A (en) | 1997-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ507378A (en) | Fusion proteins of mycobacterium tuberculosis antigens and their uses | |
| DK261386D0 (da) | Monoklonale antistoffer | |
| EP0378641A4 (en) | Novel antimicrobial peptide, compositions containing same and uses thereof | |
| ES477832A1 (es) | Un procedimiento para la preparacion de derivados de diben- zopirano. | |
| YU49126B (sh) | Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina | |
| CA2248667A1 (en) | Hla-a2.1 binding peptides and their uses | |
| ATE395361T1 (de) | Das h-y antigen | |
| DK1114156T3 (da) | Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr | |
| PT731811E (pt) | Chaperonina 10 | |
| EA201001190A1 (ru) | Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков | |
| NO971621L (no) | Keratinocyttvekstfaktoranaloger | |
| ES8704735A1 (es) | Un procedimiento para la obtencion de un anticuerpo monoclo-nal | |
| CA2137280A1 (fr) | Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications | |
| AU2001248822A1 (en) | Gd3-mimetic peptides | |
| AU3711597A (en) | A novel galanin receptor | |
| EP0972524A4 (de) | Lymphozyten aktivierungsinhibitoren | |
| PT773999E (pt) | Receptor orfao or-1 pertencente a familia de receptores nucleares | |
| Audhya et al. | Cooperativity of thymopoietin 32–36 (the active site) and thymopoietin 38–45 in receptor binding | |
| WO1994002508A3 (en) | Polypeptide antigens of mycobacterium bovis | |
| NZ508812A (en) | Peptides for the prevention or treatment of HIV | |
| DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
| NO921219D0 (no) | Somatostatin reseptor | |
| ES2000358A6 (es) | Medios para el tratamiento del cuero y su utilizacion | |
| NZ606260A (en) | Novel polypeptides involved in immune response | |
| EP0290246A3 (de) | Impfstoff zur Erzeugung einer gegen Tollwutvirus schützenden immunogenen T-Zellen-Respons |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8339 | Ceased/non-payment of the annual fee |